Item 7.01. Regulation FD Disclosure.

In January of 2023, Inspire Medical Systems, Inc. (the "Company") will be participating in various meetings with investors and analysts, and a copy of the Company's presentation materials being used at these meetings is furnished as Exhibit 99.1 hereto and is incorporated herein by reference. These presentation materials are also available on the Investor Relations page of the Company's website at https://investors.inspiresleep.com.

The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits

Exhibit No.                                               Description

99.1                       Inspire Medical Systems, Inc. Presentation, January 2023

104                      Cover Page Interactive Data File - the cover page XBRL tags are embedded
                         within the Inline XBRL document.



                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses